Patients with histologically confirmed breast cancer scheduled to receive chemotherapy with doxorubicin and cyclophosphamide (adjuvant or neoadjuvant) [clinicaltrials_resource:775f4a22700730ad6c3cfaa067a84d10]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Patients with histologically confirmed breast cancer scheduled to receive chemotherapy with doxorubicin and cyclophosphamide (adjuvant or neoadjuvant) [clinicaltrials_resource:775f4a22700730ad6c3cfaa067a84d10]
Bio2RDF identifier
775f4a22700730ad6c3cfaa067a84d10
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:775f4a22700730ad6c3cfaa067a84d10
identifier
clinicaltrials_resource:775f4a22700730ad6c3cfaa067a84d10
title
Patients with histologically c ...... mide (adjuvant or neoadjuvant)
@en
type
label
Patients with histologically c ...... f4a22700730ad6c3cfaa067a84d10]
@en